COVID-19 Continues to Circulate in Italy, Health Ministry Urges Vigilance – December 2025
Rome, Italy – Despite a general decline in cases, the Italian Ministry of Health is emphasizing that COVID-19 remains present and poses a risk, particularly to vulnerable populations, according to its latest weekly reports analyzing incidence, hospitalization, and mortality data. The reports aim to inform public health decisions and highlight the ongoing need for preventative measures.
Current COVID-19 manifestations typically present as mild symptoms resembling a common cold or flu. Common indicators include sore throat, dry cough, stuffy nose, rhinorrhea, mild or low-grade fever, persistent or intense headache, muscle and joint pain, fatigue, and general malaise. Some individuals may also experience nausea, diarrhea, and vomiting. A important number of infections are asymptomatic, yet individuals remain potentially contagious.
The Ministry notes that the elderly, immunosuppressed individuals, and those with chronic conditions face a heightened risk of developing severe illness.
While mandatory isolation following a positive SARS-CoV-2 test is no longer in affect, the Ministry of Health recommends precautionary steps to limit viral spread, including:
* Wearing FFP2 masks in indoor or crowded settings.
* Practicing rigorous hand hygiene with disinfectant gels.
* Avoiding contact with vulnerable individuals in locations like hospitals and residential care facilities (RSAs).
* Informing a general practitioner (GP) for therapeutic guidance and monitoring.
Individuals experiencing worsening symptoms, especially breathing difficulties, are advised to promptly contact their doctor or call the emergency number 118.
Mild cases generally resolve within 2-5 days, though test positivity can persist longer. Frail or elderly individuals may experience a more prolonged and complicated course, increasing the risk of hospitalization.
The Ministry stresses that, compared to the early stages of the pandemic, the current disease presentation is often milder due to widespread population immunity and vaccination. However, vigilance remains crucial, particularly with significant respiratory symptoms or intense, sudden headaches, which could signal complications or other serious medical conditions.
